Equities

BIOAGE Labs Inc

BIOAGE Labs Inc

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 202320232022
ASSETS
Cash And Short Term Investments2228
Total Receivables, Net----
Total Inventory----
Prepaid expenses0.350.39
Other current assets, total3.310
Total current assets2528
Property, plant & equipment, net0.520.37
Goodwill, net----
Intangibles, net----
Long term investments0.100
Note receivable - long term----
Other long term assets00.03
Total assets2628
LIABILITIES
Accounts payable1.872.26
Accrued expenses6.743.41
Notes payable/short-term debt390
Current portion long-term debt/capital leases6.000.17
Other current liabilities, total4.700.02
Total current liabilities585.86
Total long term debt8.202.25
Total debt532.42
Deferred income tax----
Minority interest----
Other liabilities, total0.230.15
Total liabilities678.27
SHAREHOLDERS EQUITY
Common stock00
Additional paid-in capital8.145.12
Retained earnings (accumulated deficit)(182)(118)
Treasury stock - common----
Unrealized gain (loss)----
Other equity, total0.160.17
Total equity(41)20
Total liabilities & shareholders' equity2628
Total common shares outstanding3434
Treasury shares - common primary issue00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.